Dirse V - Search Results

1

Study of diversity of anthocyanin composition in bilberry (Vaccinium myrtillus L.) fruits.

Burdulis D, Ivanauskas L, Dirse V, Kazlauskas S, Razukas A. Burdulis D, et al. Among authors: dirse v. Medicina (Kaunas). 2007;43(12):971-7. Medicina (Kaunas). 2007. PMID: 18182842 Free article.

2

[Analysis of benzodiazepine derivative mixture by gas-liquid chromatography].

Zevzikovas A, Kiliuviene G, Ivanauskas L, Dirse V. Zevzikovas A, et al. Among authors: dirse v. Medicina (Kaunas). 2002;38(3):316-20. Medicina (Kaunas). 2002. PMID: 12474705 Free article. Lithuanian.

3

[Determination of benzodiazepine derivatives mixture by high performance liquid chromatography].

Zevzikovas A, Bertulyte A, Dirse V, Ivanauskas L. Zevzikovas A, et al. Among authors: dirse v. Medicina (Kaunas). 2003;39 Suppl 2:30-6. Medicina (Kaunas). 2003. PMID: 14617855 Free article. Lithuanian.

4

[Poisonings with psychotropic drug mixtures: analysis using the thin-layer chromatography method].

Kiliuviene G, Vainauskas P, Zevzikovas A, Dirse V. Kiliuviene G, et al. Among authors: dirse v. Medicina (Kaunas). 2002;38(5):550-2. Medicina (Kaunas). 2002. PMID: 12474689 Free article. Lithuanian.

5

Synthesis and in vitro antimicrobial study of 4-thiazolidinone containing sulfanilamide.

Zevzikoviene A, Zevzikovas A, Tarasevicius E, Pavlonis A, Dirse V. Zevzikoviene A, et al. Among authors: dirse v. Acta Pol Pharm. 2012 Sep-Oct;69(5):911-5. Acta Pol Pharm. 2012. PMID: 23061287 Free article.

6

A De Novo 8q22.2q22.3 Interstitial Microdeletion in a Girl with Developmental Delay and Congenital Defects.

Kalinauskiene R, Brazdziunaite D, Burokiene N, Dirsė V, Morkuniene A, Utkus A, Preiksaitiene E. Kalinauskiene R, et al. Among authors: dirse v. Medicina (Kaunas). 2023 Jun 15;59(6):1156. doi: 10.3390/medicina59061156. Medicina (Kaunas). 2023. PMID: 37374360 Free PMC article.

7

Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial.

Norén-Nyström U, Andersen MK, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, Harila-Saari A, Heyman M, Hovland R, Häikiö S, Jónsson JJ, Karhu R, Kjeldsen E, Norberg A, Preiss BS, Pulkkinen K, Quist-Paulsen P, Räsänen H, Schmiegelow K, Seitsonen A, Sjögren H, Tammur P, Johansson B. Norén-Nyström U, et al. Among authors: dirse v. Hemasphere. 2023 May 4;7(5):e883. doi: 10.1097/HS9.0000000000000883. eCollection 2023 May. Hemasphere. 2023. PMID: 37153872 Free PMC article. No abstract available.

8

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion.

Stukaite-Ruibiene E, Norvilas R, Dirse V, Stankeviciene S, Vaitkeviciene GE. Stukaite-Ruibiene E, et al. Among authors: dirse v. Pathol Oncol Res. 2022 Sep 12;28:1610570. doi: 10.3389/pore.2022.1610570. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36172171 Free PMC article.

9

Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment.

Radzevičius M, Dirsė V, Klimienė I, Matuzevičienė R, Kučinskienė ZA, Pečeliūnas V. Radzevičius M, et al. Among authors: dirse v. Diagnostics (Basel). 2022 Aug 24;12(9):2049. doi: 10.3390/diagnostics12092049. Diagnostics (Basel). 2022. PMID: 36140450 Free PMC article.

10

Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL.

Norvilas R, Batiuskaite R, Dirse V, Semaskeviciene R, Gineikiene E, Stoskus M, Vaitkeviciene G, Rascon J, Griskevicius L. Norvilas R, et al. Among authors: dirse v. Leuk Res. 2022 May;116:106825. doi: 10.1016/j.leukres.2022.106825. Epub 2022 Mar 12. Leuk Res. 2022. PMID: 35339799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page